Conjunctival Leiomyosarcoma: A Clinico-Pathological Study With In Deep Molecular Characterization
Angela Santoro,Giuseppe Angelico,Antonino Mulè,Angelo Minucci,Federico Giannuzzi,Maria Grazia Sammarco,Monica Maria Pagliara,Maria Antonietta Blasi
DOI: https://doi.org/10.1016/j.prp.2024.155182
IF: 3.309
2024-02-07
Pathology - Research and Practice
Abstract:Background Primary and metastatic leiomyosarcomas (LMS) involving the orbital region are well known to occur however, the conjunctiva represents an extremely rare site of occurrence. Methods A 97-year-old male was referred to the Ocular Oncology Unit due to a rapidly growing painful mass (16x12x20 mm) in the nasal conjunctiva of his left eye. Wide excision followed by radiotherapy was performed. Results Based on the microscopic features (hypercellular neoplasm composed of spindle cells with cigar shaped and blunt ended nuclei with brightly eosinophilic fibrillary cytoplasm) and immunohistochemical findings (positive staining for Vimentin, Desmin, Caldesmon, and SMA and negative staining for AE1/AE3, EMA, CD117, S100, MelanA, SOX10, HMB45, TLE1, CD99, EMA and AE1 / AE3) the final diagnosis of grade 2 leyomiosarcoma was rendered. Moreover, 'in deep' DNA sequencing (>500 genes analysis) revealed a neoplasm with high TMB: 64 muts/Mb and numerous VUS and several pathogenic/oncogenic molecular alterations, including CNV loss or gain in >10 genes. At the last follow-up visit, residual disease was observed in the superior fornix, at the nasal limbus and the cornea. At the time of writing, after a follow-up of 2 month the patients is still alive without evidence of metastatic disease. Conclusion An uncommon molecular finding observed in our case was the presence of TSC1 gene mutation usually associated with soft tissue and gynecological PEComas. Our finding may harbor important therapeutic implications since the inactivation of the tumor suppressor genes TSC1 and TSC2 lead to upregulation of mTOR signaling, providing the rationale for target therapy with mTOR inhibitors. Additional studies on larger series are needed to validate our findings.
pathology